Baton Rouge specialty chemicals maker Albemarle Corp. said Monday it has expanded the kilo lab at its FDA-registered active pharmaceutical ingredient production facility in South Haven, Mich., and expects to begin production at the expanded facility in January.

The expansion will allow Albemarle to better focus on customers’ needs for smaller quantities of material specifically produced to current Good Manufacturing Practices guidelines. The expansion means Albemarle can provide customer needs throughout the entire life-cycle of their pharmaceutical products, from early stage clinical development to full-scale commercial production.